CDC meeting to consider new limits on the Johnson & Johnson vaccine over clotting issues

Welp.

The CDC is meeting today to discuss new limits on Johnson & Johnson’s COVID-19 vaccine over blood clotting issues:

Expert advisers to the CDC will discuss what U.S. health officials see as a concerning increase in the rates of a rare blood clotting disorder linked to Johnson & Johnson’s Covid vaccine. https://t.co/OudThaS19T

— The New York Times (@nytimes) December 16, 2021

According to the Washington Post, “the highest reporting rate of clot issues — about one case per 100,000 doses administered — has been in women 30 to 49 years old”:

If your Dr doesn’t consider natural immunity when advising whether risks of the vax outweigh benefits, I’d find a new Dr.

“the highest reporting rate of clot issues — about one case per 100,000 doses administered — has been in women 30 to 49 years old.”https://t.co/MDgKd5FTel

— Thomas Massie (@RepThomasMassie) December 16, 2021

And these issues have “increased since April”:

https://twitter.com/disclosetv/status/1471276787527208962

They were warned?

8 Months ago, I said the CDC should advise against J&J to women <50 — mRNA was a safer, available alternative 👇👇

Needless cases of VITT later, they slowly move in this directionhttps://t.co/LXLFOJU5mG https://t.co/EokSEAQfTW pic.twitter.com/DaLRTTMIb2

— Vinay Prasad MD MPH (@VPrasadMDMPH) December 16, 2021

We’ll keep you posted.

***